Below are the Nasdaq 100 companies that are within 21% of their respective 52-week low. Stocks that appear on our watch lists are not recommendations to buy. Instead, they are the starting point for doing your research and determining the best company to buy. Ideally, a stock that is purchased from this list is done after a considerable decline in the price and considerable due diligence.
| Name (SYMBOL) |
Price |
P/E |
EPS |
Yield |
P/B |
Pct from Yr Low |
| Activision Blizzard, Inc (ATVI) |
$10.69 |
45.49 |
0.24 |
1.40% |
1.25 |
7.65% |
| Amgen Inc. (AMGN) |
$54.69 |
11.61 |
4.71 |
0.00% |
2.42 |
15.14% |
| Apollo Group, Inc. (APOL) |
$52.78 |
13.2 |
4 |
0.00% |
6.18 |
1.11% |
| Biogen Idec Inc (BIIB) |
$50.13 |
15.18 |
3.3 |
0.00% |
2.32 |
20.07% |
| Cephalon, Inc. (CEPH) |
$60.69 |
12.1 |
5.01 |
0.00% |
1.98 |
15.49% |
| Electronic Arts Inc. (ERTS) |
$17.42 |
0 |
-2.31 |
0.00% |
2.28 |
10.96% |
| Genzyme Corporation (GENZ) |
$50.43 |
122.4 |
0.41 |
0.00% |
1.83 |
7.09% |
| Gilead Sciences, Inc. (GILD) |
$37.78 |
12.12 |
3.12 |
0.00% |
4.74 |
0.61% |
| Logitech (LOGI) |
$14.74 |
40.72 |
0.36 |
0.00% |
2.69 |
14.89% |
| QUALCOMM (QCOM) |
$37.30 |
19.89 |
1.88 |
2.00% |
3 |
5.88% |
| Ryanair Holdings plc (RYAAY) |
$24.72 |
0 |
0 |
0.00% |
0 |
4.39% |
| Sigma-Aldrich (SIAL) |
$54.23 |
18.5 |
2.93 |
1.20% |
4.01 |
21.00% |
| Staples, Inc. (SPLS) |
$22.12 |
21.62 |
1.02 |
1.60% |
2.39 |
18.16% |
| Stericycle, Inc. (SRCL) |
$56.70 |
26.83 |
2.11 |
0.00% |
5.49 |
21.00% |
| Symantec Corporation (SYMC) |
$16.12 |
18.49 |
0.87 |
0.00% |
2.89 |
15.39% |
| Yahoo! Inc. (YHOO) |
$16.39 |
29.37 |
0.56 |
0.00% |
1.84 |
17.32% |
Watch List Summary
The stock that fell the most from last week's
watch list was Apollo Group (APOL) which fell -3% for the week. Yahoo! (YHOO) gained the most for the week with 7.19%.
In all, the Nasdaq 100 Watch List of last week gained 1.15% as compared to the Nasdaq 100 index which gained 3.12%. As quickly as Cintas (CTAS) got on the Watch List is as quickly as it came off the watch list. Although CTAS is not on the watch list, I would still continue to follow the company for additional analysis and possible purchase at the right price.